Orbimed Advisors - FLEXION THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of FLEXION THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$16,893,000
-25.9%
2,769,3830.0%0.19%
-19.5%
Q2 2021$22,792,000
+10.3%
2,769,383
+20.0%
0.23%
+19.7%
Q1 2021$20,657,000
-22.4%
2,308,0830.0%0.19%
-17.2%
Q4 2020$26,635,000
+51.9%
2,308,083
+37.1%
0.23%
+5.9%
Q3 2020$17,530,000
-20.8%
1,684,0000.0%0.22%
-29.5%
Q2 2020$22,145,000
+2015.1%
1,684,000
+1166.2%
0.31%
+1633.3%
Q1 2020$1,047,000
-62.0%
133,0000.0%0.02%
-53.8%
Q4 2019$2,753,000
+148.9%
133,000
+47.9%
0.04%
+129.4%
Q2 2019$1,106,00089,9190.02%
Other shareholders
FLEXION THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,842,578$40,001,0007.32%
MILLER VALUE PARTNERS, LLC 5,274,439$54,907,0001.97%
Mesirow Financial Investment Management, Inc. 32,371$337,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,068,580$11,124,0001.25%
Clearline Capital LP 399,159$4,155,0001.09%
CLOUGH CAPITAL PARTNERS L P 1,246,150$12,972,0000.93%
Novo Holdings A/S 1,403,370$14,609,0000.72%
SNOW CAPITAL MANAGEMENT LP 303,265$3,157,0000.63%
AMERICAN FINANCIAL GROUP INC 317,700$3,308,0000.46%
Granahan Investment Management 1,257,690$13,093,0000.44%
View complete list of FLEXION THERAPEUTICS INC shareholders